8 results on '"Thomas W. Burke"'
Search Results
2. Pre-exposure cognitive performance variability is associated with severity of respiratory infection
- Author
-
Yaya Zhai, P. Murali Doraiswamy, Christopher W. Woods, Ronald B. Turner, Thomas W. Burke, Geoffrey S. Ginsburg, and Alfred O. Hero
- Subjects
Multidisciplinary - Abstract
Using data from a longitudinal viral challenge study, we find that the post-exposure viral shedding and symptom severity are associated with a novel measure of pre-exposure cognitive performance variability (CPV), defined before viral exposure occurs. Each individual’s CPV score is computed from data collected from a repeated NeuroCognitive Performance Test (NCPT) over a 3 day pre-exposure period. Of the 18 NCPT measures reported by the tests, 6 contribute materially to the CPV score, prospectively differentiating the high from the low shedders. Among these 6 are the 4 clinical measures digSym-time, digSym-correct, trail-time, and reaction-time, commonly used for assessing cognitive executive functioning. CPV is found to be correlated with stress and also with several genes previously reported to be associated with cognitive development and dysfunction. A perturbation study over the number and timing of NCPT sessions indicates that as few as 5 sessions is sufficient to maintain high association between the CPV score and viral shedding, as long as the timing of these sessions is balanced over the three pre-exposure days. Our results suggest that variations in cognitive function are closely related to immunity and susceptibility to severe infection. Further studying these relationships may help us better understand the links between neurocognitive and neuroimmune systems which is timely in this COVID-19 pandemic era.
- Published
- 2022
3. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery
- Author
-
Matthew S. Kelly, Bradly P. Nicholson, Xiling Shen, Emily M. Ko, Thomas N. Denny, Florica J Constantine, Yiling Liu, Chen Yu, Ricardo Henao, Micah T. McClain, Christopher W. Woods, Bryan Kraft, Daniel R. Saban, Elizabeth Petzold, Geoffrey S. Ginsburg, Gregory D. Sempowski, Thomas W. Burke, Robert Rolfe, Julie M Steinbrink, and Ephraim L. Tsalik
- Subjects
0301 basic medicine ,Letter ,Science ,General Physics and Astronomy ,Disease ,Biology ,Predictive markers ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,Transcriptome ,Prognostic markers ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Interferon ,Influenza, Human ,Pneumonia, Bacterial ,medicine ,Humans ,Coronavirus ,Multidisciplinary ,SARS-CoV-2 ,Sequence Analysis, RNA ,Gene Expression Profiling ,Bacterial pneumonia ,COVID-19 ,General Chemistry ,biochemical phenomena, metabolism, and nutrition ,medicine.disease ,Gene expression profiling ,030104 developmental biology ,030220 oncology & carcinogenesis ,Host-Pathogen Interactions ,Immunology ,Leukocytes, Mononuclear ,Cytokines ,Infectious diseases ,Signal transduction ,Systems biology ,Signal Transduction ,medicine.drug - Abstract
SARS-CoV-2 infection has been shown to trigger a wide spectrum of immune responses and clinical manifestations in human hosts. Here, we sought to elucidate novel aspects of the host response to SARS-CoV-2 infection through RNA sequencing of peripheral blood samples from 46 subjects with COVID-19 and directly comparing them to subjects with seasonal coronavirus, influenza, bacterial pneumonia, and healthy controls. Early SARS-CoV-2 infection triggers a powerful transcriptomic response in peripheral blood with conserved components that are heavily interferon-driven but also marked by indicators of early B-cell activation and antibody production. Interferon responses during SARS-CoV-2 infection demonstrate unique patterns of dysregulated expression compared to other infectious and healthy states. Heterogeneous activation of coagulation and fibrinolytic pathways are present in early COVID-19, as are IL1 and JAK/STAT signaling pathways, which persist into late disease. Classifiers based on differentially expressed genes accurately distinguished SARS-CoV-2 infection from other acute illnesses (auROC 0.95 [95% CI 0.92–0.98]). The transcriptome in peripheral blood reveals both diverse and conserved components of the immune response in COVID-19 and provides for potential biomarker-based approaches to diagnosis.
- Published
- 2021
4. The cost of severe haemophilia in Europe: the CHESS study
- Author
-
Charlotte Camp, Daniel-Anibal Garcia Diego, David Hughes, Liz Carroll, Thomas W. Burke, and Jamie O'Hara
- Subjects
Adult ,Haemophilia ,medicine.medical_specialty ,Adolescent ,Cost ,Health-related quality of life ,lcsh:Medicine ,Burden ,030204 cardiovascular system & hematology ,Hemophilia A ,Cohort Studies ,Young Adult ,03 medical and health sciences ,Indirect costs ,0302 clinical medicine ,Quality of life (healthcare) ,Cost of Illness ,Health care ,medicine ,Humans ,Pharmacology (medical) ,Genetics (clinical) ,Retrospective Studies ,Clotting factor ,Health economics ,business.industry ,Research ,lcsh:R ,Health Care Costs ,General Medicine ,medicine.disease ,Europe ,Cross-Sectional Studies ,Socioeconomic Factors ,030220 oncology & carcinogenesis ,Family medicine ,Quality of Life ,Observational study ,business ,Psychosocial - Abstract
Background Severe haemophilia is associated with major psychological and economic burden for patients, caregivers, and the wider health care system. This burden has been quantified and documented for a number of European countries in recent years. However, few studies have taken a standardised methodology across multiple countries simultaneously, and sought to amalgamate all three levels of burden for severe disease. The overall aim of the ‘Cost of Haemophilia in Europe: a Socioeconomic Survey’ (CHESS) study was to capture the annualised economic and psychosocial burden of severe haemophilia in five European countries. A cross-section of haemophilia specialists (surveyed between January and April 2015) provided demographic and clinical information and 12-month ambulatory and secondary care activity for patients via an online survey. In turn, patients provided corresponding direct and indirect non-medical cost information, including work loss and out-of-pocket expenses, as well as information on quality of life and adherence. The direct and indirect costs for the patient sample were calculated and extrapolated to population level. Results Clinical reports for a total of 1,285 patients were received. Five hundred and fifty-two patients (43% of the sample) provided information on indirect costs and health-related quality of life via the PSC. The total annual cost of severe haemophilia across the five countries for 2014 was estimated at EUR 1.4 billion, or just under EUR 200,000 per patient. The highest per-patient costs were in Germany (mean EUR 319,024) and the lowest were in the United Kingdom (mean EUR 129,365), with a study average of EUR 199,541. As expected, consumption of clotting factor replacement therapy represented the vast majority of costs (up to 99%). Indirect costs are driven by patient and caregiver work loss. Conclusions The results of the CHESS study reflect previous research findings suggesting that costs of factor replacement therapy account for the vast majority of the cost burden in severe haemophilia. However, the importance of the indirect impact of haemophilia on the patient and family should not be overlooked. The CHESS study highlights the benefits of observational study methodologies in capturing a ‘snapshot’ of information for patients with rare diseases.
- Published
- 2017
5. Multiplex detection of disease biomarkers using SERS molecular sentinel-on-chip
- Author
-
Hsin-Neng Wang, Hoan T. Ngo, Tuan Vo-Dinh, Geoffrey S. Ginsburg, and Thomas W. Burke
- Subjects
Silver ,Time Factors ,Oligonucleotides ,DNA, Single-Stranded ,Biosensing Techniques ,Computational biology ,Spectrum Analysis, Raman ,Biochemistry ,Mass Spectrometry ,DNA sequencing ,Analytical Chemistry ,Nucleic acid thermodynamics ,chemistry.chemical_compound ,Humans ,Nanotechnology ,Multiplex ,Antigens ,Gene ,Chemistry ,DNA–DNA hybridization ,Membrane Proteins ,Nucleic Acid Hybridization ,DNA ,Molecular biology ,Biomarker (cell) ,Cytoskeletal Proteins ,Immune System ,Microscopy, Electron, Scanning ,Nucleic acid ,Biological Assay ,Gold ,Biomarkers - Abstract
Developing techniques for multiplex detection of disease biomarkers is important for clinical diagnosis. In this work, we have demonstrated for the first time the feasibility of multiplex detection of genetic disease biomarkers using the surface-enhanced Raman scattering (SERS)-based molecular sentinel-on-chip (MSC) diagnostic technology. The molecular sentinel (MS) sensing mechanism is based upon the decrease of SERS intensity when Raman labels tagged at 3'-ends of MS nanoprobes are physically displaced from the nanowave chip's surface upon DNA hybridization. The use of bimetallic layer (silver and gold) for the nanowave fabrication was investigated. SERS measurements were performed immediately following a single hybridization reaction between the target single-stranded DNA sequences and the complementary MS nanoprobes immobilized on the nanowave chip without requiring target labeling (i.e., label-free), secondary hybridization, or post-hybridization washing, thus shortening the assay time and reducing cost. Two nucleic acid transcripts, interferon alpha-inducible protein 27 and interferon-induced protein 44-like, are used as model systems for the multiplex detection concept demonstration. These two genes are well known for their critical role in host immune response to viral infection and can be used as molecular signature for viral infection diagnosis. The results indicate the potential of the MSC technology for nucleic acid biomarker multiplex detection.
- Published
- 2014
6. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer
- Author
-
David M. Gershenson, Ana Aleman, Michael W. Bevers, J.T. Wharton, Naoto T. Ueno, J. G. Gajewski, C. Levenback, Diane Bodurka-Bevers, Richard E. Champlin, Thomas W. Burke, J. Boyer, Cindy Ippoliti, M. Donato, Paolo Anderlini, Jo Lauppe, Jeffrey J. Molldrem, Judith K. Wolf, Ralph S. Freedman, Martin Korbling, Sergio Giralt, and Robert C. Bast
- Subjects
Adult ,medicine.medical_specialty ,Filgrastim ,medicine.medical_treatment ,Urology ,Hematopoietic stem cell transplantation ,Transplantation, Autologous ,Antineoplastic Combined Chemotherapy Protocols ,Granulocyte Colony-Stimulating Factor ,medicine ,Humans ,Ifosfamide ,Etoposide ,Hematopoietic Stem Cell Mobilization ,Mesna ,Ovarian Neoplasms ,Transplantation ,Chemotherapy ,business.industry ,Carcinoma ,Hematopoietic Stem Cell Transplantation ,Hematology ,Middle Aged ,Combined Modality Therapy ,Recombinant Proteins ,Surgery ,Granulocyte colony-stimulating factor ,Blood Component Removal ,Female ,business ,medicine.drug - Abstract
High-dose chemotherapy combined with autologous peripheral blood stem cell transplantation has shown promise as treatment for recurrent or persistent epithelial ovarian cancer. We evaluated the stem cell mobilization regimen of high-dose ifosfamide plus etoposide in 32 patients with epithelial ovarian cancer, who had a positive second-look laparatomy or recurrent disease. Ifosfamide was given at 10 g/m2 by continuous i.v. from days 1 to 3. Etoposide was given at 150 mg/m2 every 12 h for six doses on days 1-3. Filgrastim was given at 10 microg/kg/d s.c. from day 5 until the completion of peripheral blood stem cell harvest. Fourteen of 32 patients had measurable or evaluable disease before mobilization therapy and were assessed for response. In nine (64%) of the 14 patients, treatment response was demonstrated, and these patients received a second cycle of mobilization therapy. The target CD34+ cell dose (>8 x 106 cells/kg) was achieved with a median of one apheresis (range 1-5). A median of 25.1 (range 8.0-122.5) x 106 CD34+ cells/kg body weight was collected. Non-hematologic toxicity was limited to grade 2 renal dysfunction in one patient and grade 2 hepatic dysfunction in three patients. In this patient group, high-dose ifosfamide plus etoposide with filgrastim support was well tolerated, lead to successful stem cell harvest and had antitumor activity.
- Published
- 2000
7. Modified instruments for mobilization of the ureters and parametrial transsection during radical hysterectomy
- Author
-
D.G. Kieback and Thomas W. Burke
- Subjects
medicine.medical_specialty ,Mobilization ,business.industry ,Parametrial ,Dissection ,Uterus ,Hysterectomy ,Surgery ,Ureter ,medicine.anatomical_structure ,Oncology ,Surgical oncology ,Parametrium ,Humans ,Medicine ,Female ,Radical Hysterectomy ,business - Abstract
The untunneling of the ureters and the transsection of the parametria are two well-characterized steps of radical hysterectomy. Two sets of instruments were developed to facilitate the mobilization (untunneling) of the ureters and the dissection of the paravaginal and parametrial tissues during radical hysterectomy.Instrument set one consists of a modified Uchida spoon, two ureteral tunnel clamps, and a pair of tunnel scissors. Set two contains a long and a short sharply angled parametrial clamp with matching parametrial scissors.This technique permits one-step exposure of the ureter, protected from injury by the spoon. The instruments for parametrial transsection facilitate controlled transsection of the paravaginal and parametrial tissues while conserving surgical margins. They can also be conveniently used for transsection of the uterosacral ligaments.The authors believe that the instruments contribute to an enhanced safety and accuracy of radical hysterectomy with improved efficiency by shortened operating time.
- Published
- 1995
8. Comparing reference-based RNA-Seq mapping methods for non-human primate data
- Author
-
Joseph E. Lucas, Thomas W. Burke, Geoffrey S. Ginsburg, Ashlee M. Benjamin, and Marshall Nichols
- Subjects
Male ,Sequence analysis ,Sequence assembly ,Genomics ,RNA-Seq ,Computational biology ,Biology ,Genome ,Genetics ,Animals ,Sequence Analysis, RNA ,Chromosome Mapping ,High-Throughput Nucleotide Sequencing ,Reference Standards ,Biological Evolution ,Mapping ,RNA-Sequencing ,RNA ,Human genome ,DNA microarray ,Transcriptome ,Papio ,Research Article ,Biotechnology ,Reference genome - Abstract
Background The application of next-generation sequencing technology to gene expression quantification analysis, namely, RNA-Sequencing, has transformed the way in which gene expression studies are conducted and analyzed. These advances are of particular interest to researchers studying organisms with missing or incomplete genomes, as the need for knowledge of sequence information is overcome. De novo assembly methods have gained widespread acceptance in the RNA-Seq community for organisms with no true reference genome or transcriptome. While such methods have tremendous utility, computational cost is still a significant challenge for organisms with large and complex genomes. Results In this manuscript, we present a comparison of four reference-based mapping methods for non-human primate data. We utilize TopHat2 and GSNAP for mapping to the human genome, and Bowtie2 and Stampy for mapping to the human genome and transcriptome for a total of six mapping approaches. For each of these methods, we explore mapping rates and locations, number of detected genes, correlations between computed expression values, and the utility of the resulting data for differential expression analysis. Conclusions We show that reference-based mapping methods indeed have utility in RNA-Seq analysis of mammalian data with no true reference, and the details of mapping methods should be carefully considered when doing so. Critical algorithm features include short seed sequences, the allowance of mismatches, and the allowance of gapped alignments in addition to splice junction gaps. Such features facilitate sensitive alignment of non-human primate RNA-Seq data to a human reference. Electronic supplementary material The online version of this article (doi:10.1186/1471-2164-15-570) contains supplementary material, which is available to authorized users.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.